Infectious Disease Frontier

Editor's Note: With the widespread adoption of antiretroviral therapy (ART), AIDS has gradually become a manageable chronic condition. However, approximately 600,000 people worldwide still die from advanced HIV disease annually,…

Editor's Note: The 2025 Asia-Pacific AIDS & Co-Infections Conference (APACC 2025) serves as the region's premier academic platform, focusing on cutting-edge issues in HIV prevention and control. At this conference,…

Editor's Note: The 2025 Asia-Pacific AIDS & Co-Infections Conference (APACC 2025) recently concluded successfully in Tokyo, Japan. The conference centered on advances, key issues, and practical needs in HIV and…

Editor's Note: At the recent 2025 Asia-Pacific AIDS & Co-Infections Conference (APACC 2025), Dr. Thomas Fitzpatrick from the University of Washington presented his study titled "Pay-It-Forward and Social Network Distribution…

At ESCMID Global 2025, Infectious Disease Frontier interviewed Dr. Francesco Cogliati Dezza to explore the renewed clinical relevance of temocillin. With resistance to broad-spectrum antibiotics on the rise, temocillin is…

At ESCMID Global 2025, Infectious Disease Frontier sat down with Dr. Francesco Cogliati Dezza to discuss the renewed clinical relevance of temocillin. As resistance to broad-spectrum antibiotics continues to rise,…

At ESCMID Global 2025, one of the world’s leading forums for infectious disease and clinical microbiology, congenital cytomegalovirus (CMV) took center stage as experts explored new avenues in screening, prevention,…

At ESCMID Global 2025, antimicrobial resistance stood out as one of the most pressing topics. As carbapenem resistance rises to alarming levels worldwide, the medical community is urgently seeking viable…